Oral Drug Delivery Market Size, Share, Growth Analysis, Forecast Report 2021-2028

Oral Drug Delivery Market

Oral Drug Delivery Market By Type (Controlled Release, Orodispersible Tablets and others), By End Users (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers and others), By Product (tablets, syrups and others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 - 2028

Category: Medical Device Report Format : PDF Pages: 150 Report Code: ZMR-5656 Published Date: Feb-2023 Status : Published
Market Size in 2020 Market Forecast in 2028 CAGR (in %) Base Year
USD 119.92 Billion USD 220.32 Billion 9.7% 2020

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Type
        • 2.1.1.2. Market Attractiveness Analysis, By End Users
        • 2.1.1.3. Market Attractiveness Analysis, By Product
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Oral Drug Delivery Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Oral Drug Delivery Market – Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Type , 2020 & 2028
    • 4.2. Contrulled Release
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Orodispersible Tablets
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Oral Drug Delivery Market – End Users Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End Users , 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Diagnostic Centers
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Ambulatory Surgical Centers
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Oral Drug Delivery Market – Product Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Product , 2020 & 2028
    • 6.2. tablets
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. syrups
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Oral Drug Delivery Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Type , 2016 – 2028
      • 7.2.3. North America Market Revenue, By End Users , 2016 – 2028
      • 7.2.4. North America Market Revenue, By Product , 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Type , 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By End Users , 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Product , 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Type , 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By End Users , 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Product , 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Type , 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By End Users , 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Product , 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Type , 2016 – 2028
      • 7.3.3. Europe Market Revenue, By End Users , 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Product , 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Type , 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By End Users , 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Product , 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Type , 2016 – 2028
        • 7.3.6.2. France Market Revenue, By End Users , 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Product , 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Type , 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By End Users , 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Product , 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Type , 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By End Users , 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Product , 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Type , 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By End Users , 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Product , 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Type , 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By End Users , 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Product , 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Type , 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By End Users , 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Product , 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Type , 2016 – 2028
        • 7.4.5.2. China Market Revenue, By End Users , 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Product , 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Type , 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By End Users , 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Product , 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Type , 2016 – 2028
        • 7.4.7.2. India Market Revenue, By End Users , 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Product , 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Type , 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By End Users , 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Product , 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Type , 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By End Users , 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Product , 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Type , 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By End Users , 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Product , 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Type , 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By End Users , 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Product , 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Type , 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By End Users , 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Product , 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Type , 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By End Users , 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Product , 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Type , 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By End Users , 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Product , 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Type , 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By End Users , 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Product , 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Type , 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By End Users , 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Product , 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Type , 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By End Users , 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Product , 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Type , 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By End Users , 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Product , 2016 – 2028
  • Chapter No. 8 Oral Drug Delivery Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Oral Drug Delivery Market: Company Market Share, 2019
      • 9.1.2. Global Oral Drug Delivery Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Oral Drug Delivery Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Oral Drug Delivery Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. AdhexPharma
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Protalix
    • 10.3. CURE Pharamceutical
    • 10.4. Evonik
    • 10.5. Arx LLC
    • 10.6. Catalent Inc.
    • 10.7. INTELGENX CORP
    • 10.8. Assembly Biosciences Inc.
    • 10.9. Aquestive Therapeutics
    • 10.10. Emisphere Technulogies
    • 10.11. ZIM Laboratories Limited
    • 10.12. Adare Pharmaceuticals
    • 10.13. Merrion Pharmaceuticals Plc
    • 10.14. Oramed Pharmaceuticals
    • 10.15. Samyang Corporation
    • 10.16. Chimerix Inc.
    • 10.17. Skypepharma
    • 10.18. Amcor Limited
    • 10.19. Unigene Laboratories Inc.
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Table Of Figures

List of Figures

FIG NO. 1. Market Attractiveness Analysis, By Type
FIG NO. 2. Market Attractiveness Analysis, By End Users
FIG NO. 3. Market Attractiveness Analysis, By Product
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Oral Drug Delivery  Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Type , 2020 & 2028
FIG NO. 8. Global Oral Drug Delivery  Market for Controlled Release, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Oral Drug Delivery  Market for Controlled Release, By Country, 2020 & 2028
FIG NO. 10. Global Oral Drug Delivery  Market for Orodispersible Tablets , Revenue (USD Million) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Oral Drug Delivery  Market for Orodispersible Tablets , By Country, 2020 & 2028
FIG NO. 12. Market Revenue Share, By End Users , 2020 & 2028
FIG NO. 13. Global Oral Drug Delivery  Market for Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Oral Drug Delivery  Market for Hospitals, By Country, 2020 & 2028
FIG NO. 15. Global Oral Drug Delivery  Market for Diagnostic Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Oral Drug Delivery  Market for Diagnostic Centers, By Country, 2020 & 2028
FIG NO. 17. Global Oral Drug Delivery  Market for Ambulatory Surgical Centers , Revenue (USD Million) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Oral Drug Delivery  Market for Ambulatory Surgical Centers , By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By Product , 2020 & 2028
FIG NO. 20. Global Oral Drug Delivery  Market for tablets, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Oral Drug Delivery  Market for tablets, By Country, 2020 & 2028
FIG NO. 22. Global Oral Drug Delivery  Market for syrups , Revenue (USD Million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Oral Drug Delivery  Market for syrups , By Country, 2020 & 2028
FIG NO. 24. Global Oral Drug Delivery  Market Revenue Share, By Region, 2020 & 2028
FIG NO. 25. North America Oral Drug Delivery  Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 26. Porter’s Five Forces Analysis for Global Oral Drug Delivery  Market
FIG NO. 27. PEST Analysis for Global Oral Drug Delivery  Market
FIG NO. 28. Pricing Analysis for Global Oral Drug Delivery  Market
FIG NO. 29. Value Chain Analysis for Global Oral Drug Delivery  Market
FIG NO. 30. Company Share Analysis, 2019
FIG NO. 31. Radar Determinant Chart, 2019
FIG NO. 32. Company Strategic Developments – Heat Map Analysis
FIG NO. 33. AdhexPharma Business Segment Revenue Share, 2020 (%)
FIG NO. 34. AdhexPharma Geographical Segment Revenue Share, 2020 (%)
FIG NO. 35. Market Channels
FIG NO. 36. Marketing Channel Development Trend
FIG NO. 37. Growth in World Gross Product, 2008-2018
FIG NO. 38. Research Methodology – Detailed View
FIG NO. 39. Research Methodology
 


Table Of Tables

List of Tables

TABLE NO. 1. Global Oral Drug Delivery  Market: Snapshot
TABLE NO. 2. Quarterly Oral Drug Delivery  Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Oral Drug Delivery  Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 6. Global Oral Drug Delivery  Market for Controlled Release, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Oral Drug Delivery  Market for Orodispersible Tablets , by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global Oral Drug Delivery  Market for Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global Oral Drug Delivery  Market for Diagnostic Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Oral Drug Delivery  Market for Ambulatory Surgical Centers , by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Oral Drug Delivery  Market for tablets, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Oral Drug Delivery  Market for syrups , by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Oral Drug Delivery  Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 14. North America Oral Drug Delivery  Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 15. North America Oral Drug Delivery  Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 16. North America Oral Drug Delivery  Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 17. North America Oral Drug Delivery  Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 18. U.S. Oral Drug Delivery  Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 19. U.S. Oral Drug Delivery  Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 20. U.S. Oral Drug Delivery  Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 21. Canada Oral Drug Delivery  Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 22. Canada Oral Drug Delivery  Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 23. Canada Oral Drug Delivery  Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 24. Mexico Oral Drug Delivery  Market Revenue, By Type , 2016 – 2028 (USD Million)
TABLE NO. 25. Mexico Oral Drug Delivery  Market Revenue, By End Users , 2016 – 2028 (USD Million)
TABLE NO. 26. Mexico Oral Drug Delivery  Market Revenue, By Product , 2016 – 2028 (USD Million)
TABLE NO. 27. Drivers for the Oral Drug Delivery  Market: Impact Analysis
TABLE NO. 28. Restraints for the Oral Drug Delivery  Market: Impact Analysis
TABLE NO. 29. Major Buyers of Oral Drug Delivery
TABLE NO. 30. Distributors/Traders List of Oral Drug Delivery
TABLE NO. 31. Global Oral Drug Delivery  Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 32. Global Oral Drug Delivery  Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)

Methodology

FrequentlyAsked Questions

The global oral drug delivery market size was USD 119.92 billion in 2020.

The Global Oral Drug Delivery Market size is expected to reach USD 220.32 Billion by 2028, growing at a CAGR of 7.9% between 2021 to 2028.

The rising prevalence of the chronic diseases has been driving the oral drug delivery market. The growth in the research and development by various pharmaceutical companies has boosted the market. Among the drug delivery routes, oral drug delivery is most preferred one in various therapeutic areas which is also the reason to boost this market. The growth in the biologics market and the increasing penetration of health insurance will boost the market growth.

North America held a share of 39% in 2020. This is due to the factors such as presence of large number of pharmaceutical companies, robust pharmaceutical industry, drug delivery technology providers and rising number of collaborations between technology providers and pharmaceutical companies. Also, the increased demand for self-administration and home healthcare devices, transdermal patches and transmucosal systems for chronic diseases and increasing applications of inhalers have boosted the market in this region.

Some of the key players in the Oral Drug Delivery market include AdhexPharma, Protalix, CURE Pharmaceutical, Evonik, Arx LLC, Catalent Inc., INTELGENX CORP, Assembly Biosciences Inc., Aquestive Therapeutics, Emisphere Technologies, ZIM Laboratories Limited, Adare Pharmaceuticals, Merrion Pharmaceuticals Plc, Oramed Pharmaceuticals, Samyang Corporation, Chimerix Inc., Skypepharma, Amcor Limited and Unigene Laboratories Inc. among others.

Choose License Type

  • zion payment modes

List of Contents

Market SizeCOVID-19 Impact AnalysisGrowth FactorsMarket Segment Analysis ByTypeEnd Users AnalysisMarket ShareReport ScopeRegional AnalysisKey Market Players Competitive LandscapeThe Global Market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed